How to follow the new EU Council recommendation and improve
prostate cancer early detection: the Prostaforum 2022
declaration

J 2023

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

MÁJEK, Ondřej, Marek BABJUK, Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK et. al.

Základní údaje

Originální název

How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

Autoři

MÁJEK, Ondřej (203 Česká republika, domácí), Marek BABJUK (203 Česká republika), Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK, Roman ZACHOVAL (203 Česká republika), Jiri FERDA (203 Česká republika), Marcela KOUDELKOVÁ (203 Česká republika, domácí), Ondřej NGO (203 Česká republika, domácí), Jakub GREGOR (203 Česká republika, domácí), Sarah COLLEN, Karel HEJDUK (203 Česká republika, domácí), Ladislav DUŠEK (203 Česká republika, domácí) a Vlastimil VÁLEK (203 Česká republika, domácí)

Vydání

EUROPEAN UROLOGY OPEN SCIENCE, AMSTERDAM, ELSEVIER, 2023, 2666-1691

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30217 Urology and nephrology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.500 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133367

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.euros.2023.05.011

UT WoS

001055274700001

Klíčová slova anglicky

Cancer screening; Pilot studies; Prostate cancer

Štítky

14110216, 14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 1. 2. 2024 10:10, Mgr. Tereza Miškechová

Anotace

V originále

An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration.Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.& COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).

Citovat

MÁJEK, Ondřej, Marek BABJUK, Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK, Roman ZACHOVAL, Jiri FERDA, Marcela KOUDELKOVÁ, Ondřej NGO, Jakub GREGOR, Sarah COLLEN, Karel HEJDUK, Ladislav DUŠEK a Vlastimil VÁLEK. How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration. EUROPEAN UROLOGY OPEN SCIENCE. AMSTERDAM: ELSEVIER, 2023, roč. 53, July 2023, s. 106-108. ISSN 2666-1691. Dostupné z: https://dx.doi.org/10.1016/j.euros.2023.05.011.

@article{2368530,
   author = {Májek, Ondřej and Babjuk, Marek and Roobol, Monique J and Bratt, Ola and Hendrik, Van Poppel and Zachoval, Roman and Ferda, Jiri and Koudelková, Marcela and Ngo, Ondřej and Gregor, Jakub and Collen, Sarah and Hejduk, Karel and Dušek, Ladislav and Válek, Vlastimil},
   article_location = {AMSTERDAM},
   article_number = {July 2023},
   doi = {http://dx.doi.org/10.1016/j.euros.2023.05.011},
   keywords = {Cancer screening; Pilot studies; Prostate cancer},
   language = {eng},
   issn = {2666-1691},
   journal = {EUROPEAN UROLOGY OPEN SCIENCE},
   title = {How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration},
   url = {https://www.sciencedirect.com/science/article/pii/S2666168323002525?via%3Dihub},
   volume = {53},
   year = {2023}
}

TY  - JOUR
ID  - 2368530
AU  - Májek, Ondřej - Babjuk, Marek - Roobol, Monique J - Bratt, Ola - Hendrik, Van Poppel - Zachoval, Roman - Ferda, Jiri - Koudelková, Marcela - Ngo, Ondřej - Gregor, Jakub - Collen, Sarah - Hejduk, Karel - Dušek, Ladislav - Válek, Vlastimil
PY  - 2023
TI  - How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
JF  - EUROPEAN UROLOGY OPEN SCIENCE
VL  - 53
IS  - July 2023
SP  - 106-108
EP  - 106-108
PB  - ELSEVIER
SN  - 26661691
KW  - Cancer screening
KW  - Pilot studies
KW  - Prostate cancer
UR  - https://www.sciencedirect.com/science/article/pii/S2666168323002525?via%3Dihub
N2  - An updated Council of the EU recommendation on cancer screening was adopted in December 2022 during the Czech EU presidency. The recommendation included prostate cancer as a suitable target disease for organised screening, and invited countries to proceed with piloting and further research. To support further discussions and actions to promote early detection of prostate cancer, an international conference in November 2022 (Prostaforum 2022) resulted in a joint declaration. Here we describe the EU policy background, summarise the preparation of the declaration and the key underlying evidence and expert recommendations, and report the text of the declaration. The declaration summarises the striking inequalities in prostate cancer burden in Europe and calls on all stakeholders to consider and support concrete steps for advancement of organised early detection of prostate cancer. Our aim is to request endorsement of the text and potential initiation of practical actions by all stakeholders to support the aims of the declaration.Patient summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot programmes for prostate cancer screening. The Prostaforum 2022 declaration invites all stakeholders to support this new recommendation with specific steps.& COPY; 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
ER  -

MÁJEK, Ondřej, Marek BABJUK, Monique J ROOBOL, Ola BRATT, Van Poppel HENDRIK, Roman ZACHOVAL, Jiri FERDA, Marcela KOUDELKOVÁ, Ondřej NGO, Jakub GREGOR, Sarah COLLEN, Karel HEJDUK, Ladislav DUŠEK a Vlastimil VÁLEK. How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration. \textit{EUROPEAN UROLOGY OPEN SCIENCE}. AMSTERDAM: ELSEVIER, 2023, roč.~53, July 2023, s.~106-108. ISSN~2666-1691. Dostupné z: https://dx.doi.org/10.1016/j.euros.2023.05.011.

Podrobný výpis o publikaci